tm logo
XILFYA
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 30 May 2022

Last Applicant/ Owned by

235 East 42nd St.

New York

NY

10017

Serial Number

88693852 filed on 15th Nov 2019

Registration Number

N/A

Correspondent Address

Richard A. Friedman

PFIZER INC.

235 EAST 42ND ST.

NEW YORK NY 10017

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

XILFYA

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations forRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, anti-fungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Mark Details


Serial Number

No 88693852

Mark Type

No Service/Collective Mark

Attorney Docket Number

No T428893

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
31st May 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
30th May 2022ABANDONMENT - NO USE STATEMENT FILED
30th Sep 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
28th Sep 2021SOU EXTENSION 3 GRANTED
28th Sep 2021SOU EXTENSION 3 FILED
28th Sep 2021TEAS EXTENSION RECEIVED
19th Mar 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17th Mar 2021SOU EXTENSION 2 GRANTED
17th Mar 2021SOU EXTENSION 2 FILED
17th Mar 2021TEAS EXTENSION RECEIVED